Recently appointed CEO of Saudi Chemical Company Holding’s Pharma Sector, Ismail Shehada is today drawing on 20+ years of Big Pharma experience to drive SCCH’s growing life sciences footprint in alignment with the Kingdom of Saudi Arabia’s Vision 2030 healthcare transformation. Shehada explains how SCCH is moving into third-party logistics and the manufacturing of biotech products and why this heralds “a new era” for healthcare service provision in the country.
I like the fact that Vision 2030 does not only focus on the localisation of products, but on the country’s human capital itself and the transfer of know-how from around the world to local people
